WTI options expiry leads CME Group stock lower by 2.25%

Traders Union
All News
Companies
CME Group slides 2.25% today

Highlights

CME Group is experiencing near-term selling pressure but retains a strong medium- and long-term uptrend above its major support levels.
Momentum indicators are mixed, with some overbought warning signals and a stalled advance following recent gains and a 2.25% intraday drop.
CME is projected to consolidate in the $295.00–$312.00 range next week, with strong upside recovery probabilities and downside limited unless support at $295.00 breaks.

Uptrend durability tested as near-term resistance limits recovery

CME Group is trading at $303.60, slightly below its MA-20 ($304.75) and MA-50 ($304.93), but well above the MA-200 ($280.29), indicating near-term seller pressure within a broadly intact medium- and long-term uptrend. The Ichimoku Kijun is set at $310.89, marking immediate resistance; nearby support levels are found at MA-100 ($289.72) and key support at MA-200 ($280.29), while near-term resistance is clustered between MA-20 and MA-50, with key resistance at the Ichimoku Kijun.

Buyer exhaustion emerges as overbought signals counter recent selloff

Momentum signals on D1 are mixed, with MACD showing a strong sell while ADX reads neutral, reflecting a stall after recent gains. Oscillator readings flag overbought conditions for Stoch RSI and BBP, while RSI and CCI remain in moderate buy territory. BBP confirms buyer dominance but sits at an overbought extreme, suggesting upside momentum is stretched. In today's session, CME has dropped 2.25% from the open, underscoring renewed selling pressure. Over the past week, CME has slipped $1.51 (0.46%) from a prior close of $305.11, with the current price pinned at the bottom of the weekly range and weekly volatility standing at 3.37%. The tone is one of steady decline off the week’s high.

Upside recovery favored as technical signals outweigh downside risk

For the coming week, CME is expected to trade within a normalized range of $295.00 to $312.00, comfortably above the 52-week low ($251.90) and well below the year’s high ($329.16). Short-term probabilities favor a move higher, with a very high probability (more than 80%) of price recovery based on three buy signals (RSI-W1, ADX-W1, MA-50-W1) versus one on MACD-W1, making a decline much less likely. The baseline scenario is for the price to consolidate between the $295.00 support and $312.00 resistance area. A bullish scenario would see a break above $312.00, challenging immediate resistance with room to retest higher annual levels. A bearish scenario would unfold if support at $295.00 gives way, exposing a slide toward $289.00–$290.00, though long-term trend signals still point up.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that CME Group was experiencing short- and medium-term downside pressure, but retained a constructive long-term outlook amid ongoing market indecision. This article adds an updated assessment, encouraging readers to monitor whether current price action confirms stabilization or signals a move toward a decisive breakout from recent consolidation.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.